Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11


Ebola virus entry into host cells: identifying therapeutic strategies.

Rhein BA, Maury WJ.

Curr Clin Microbiol Rep. 2015 Sep;2(3):115-124. Epub 2015 Jul 1.


AMP-activated protein kinase is required for the macropinocytic internalization of ebolavirus.

Kondratowicz AS, Hunt CL, Davey RA, Cherry S, Maury WJ.

J Virol. 2013 Jan;87(2):746-55. doi: 10.1128/JVI.01634-12. Epub 2012 Oct 31.


Ebolavirus: a brief review of novel therapeutic targets.

Kondratowicz AS, Maury WJ.

Future Microbiol. 2012 Jan;7(1):1-4. doi: 10.2217/fmb.11.110. Review. No abstract available.


Hypericum in infection: Identification of anti-viral and anti-inflammatory constituents.

Birt DF, Widrlechner MP, Hammer KD, Hillwig ML, Wei J, Kraus GA, Murphy PA, McCoy J, Wurtele ES, Neighbors JD, Wiemer DF, Maury WJ, Price JP.

Pharm Biol. 2009;47(8):774-782.


Echinacea in infection.

Birt DF, Widrlechner MP, Lalone CA, Wu L, Bae J, Solco AK, Kraus GA, Murphy PA, Wurtele ES, Leng Q, Hebert SC, Maury WJ, Price JP.

Am J Clin Nutr. 2008 Feb;87(2):488S-92S.


Drug induced superinfection in HIV and the evolution of drug resistance.

Leontiev VV, Maury WJ, Hadany L.

Infect Genet Evol. 2008 Jan;8(1):40-50. Epub 2007 Sep 29.


Manipulation of P-TEFb control machinery by HIV: recruitment of P-TEFb from the large form by Tat and binding of HEXIM1 to TAR.

Sedore SC, Byers SA, Biglione S, Price JP, Maury WJ, Price DH.

Nucleic Acids Res. 2007;35(13):4347-58. Epub 2007 Jun 18.


Cellular and viral specificity of equine infectious anemia virus Tat transactivation.

Maury WJ, Carpenter S, Graves K, Chesebro B.

Virology. 1994 May 1;200(2):632-42.


Supplemental Content

Loading ...
Support Center